278 related articles for article (PubMed ID: 27346133)
21. [Inhibition of respiratory syncytial virus replication in cultured cells by RNA-cleaving DNAzyme].
Zhao CA; Zhao XD; Yu HG; Wu YP; Yang XQ
Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):594-7. PubMed ID: 14744382
[TBL] [Abstract][Full Text] [Related]
22. Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase.
Liuzzi M; Mason SW; Cartier M; Lawetz C; McCollum RS; Dansereau N; Bolger G; Lapeyre N; Gaudette Y; Lagacé L; Massariol MJ; Dô F; Whitehead P; Lamarre L; Scouten E; Bordeleau J; Landry S; Rancourt J; Fazal G; Simoneau B
J Virol; 2005 Oct; 79(20):13105-15. PubMed ID: 16189012
[TBL] [Abstract][Full Text] [Related]
23. The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling.
Varghese FS; Thaa B; Amrun SN; Simarmata D; Rausalu K; Nyman TA; Merits A; McInerney GM; Ng LFP; Ahola T
J Virol; 2016 Nov; 90(21):9743-9757. PubMed ID: 27535052
[TBL] [Abstract][Full Text] [Related]
24. Respiratory Syncytial Virus Replication Is Promoted by Autophagy-Mediated Inhibition of Apoptosis.
Li M; Li J; Zeng R; Yang J; Liu J; Zhang Z; Song X; Yao Z; Ma C; Li W; Wang K; Wei L
J Virol; 2018 Apr; 92(8):. PubMed ID: 29386287
[TBL] [Abstract][Full Text] [Related]
25. Tiotropium bromide attenuates respiratory syncytial virus replication in epithelial cells.
Iesato K; Tatsumi K; Saito K; Ogasawara T; Sakao S; Tada Y; Kasahara Y; Kurosu K; Tanabe N; Takiguchi Y; Kuriyama T; Shirasawa H
Respiration; 2008; 76(4):434-41. PubMed ID: 18728351
[TBL] [Abstract][Full Text] [Related]
26. Effects of mitogen-activated protein kinase inhibitors on tumor necrosis factor-alpha gene expression and apoptosis induction in cultured human fetal membrane chorion cells infected with influenza virus.
Uchide N; Ohyama K; Bessho T; Toyoda H
Intervirology; 2007; 50(2):99-107. PubMed ID: 17139186
[TBL] [Abstract][Full Text] [Related]
27. [Protein kinase inhibitor flavopiridol inhibits the replication of influenza virus in vitro].
Wang S; Zhang J; Ye X
Wei Sheng Wu Xue Bao; 2012 Sep; 52(9):1137-42. PubMed ID: 23236848
[TBL] [Abstract][Full Text] [Related]
28. Activation of ERK2 by respiratory syncytial virus in A549 cells is linked to the production of interleukin 8.
Chen W; Monick MM; Carter AB; Hunninghake GW
Exp Lung Res; 2000; 26(1):13-26. PubMed ID: 10660833
[TBL] [Abstract][Full Text] [Related]
29. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
30. Respiratory Syncytial Virus Inhibitor AZ-27 Differentially Inhibits Different Polymerase Activities at the Promoter.
Noton SL; Nagendra K; Dunn EF; Mawhorter ME; Yu Q; Fearns R
J Virol; 2015 Aug; 89(15):7786-98. PubMed ID: 25995255
[TBL] [Abstract][Full Text] [Related]
31. NJK14047 inhibition of p38 MAPK ameliorates inflammatory immune diseases by suppressing T cell differentiation.
Lee JH; Lee JE; Son SE; Son SH; Kim NJ; Im DS
Int Immunopharmacol; 2024 Mar; 130():111800. PubMed ID: 38447416
[TBL] [Abstract][Full Text] [Related]
32. Potent inhibition of respiratory syncytial virus by combination treatment with 2-5A antisense and ribavirin.
Xu Z; Kuang M; Okicki JR; Cramer H; Chaudhary N
Antiviral Res; 2004 Mar; 61(3):195-206. PubMed ID: 15168801
[TBL] [Abstract][Full Text] [Related]
33. DMO-CAP inhibits influenza virus replication by activating heme oxygenase-1-mediated IFN response.
Zhong M; Wang H; Ma L; Yan H; Wu S; Gu Z; Li Y
Virol J; 2019 Feb; 16(1):21. PubMed ID: 30786886
[TBL] [Abstract][Full Text] [Related]
34. Ginseng protects against respiratory syncytial virus by modulating multiple immune cells and inhibiting viral replication.
Lee JS; Lee YN; Lee YT; Hwang HS; Kim KH; Ko EJ; Kim MC; Kang SM
Nutrients; 2015 Feb; 7(2):1021-36. PubMed ID: 25658239
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of selective inhibition of respiratory syncytial virus by a benzodithiin compound (RD3-0028).
Sudo K; Konno K; Watanabe W; Shigeta S; Yokota T
Microbiol Immunol; 2001; 45(7):531-7. PubMed ID: 11529559
[TBL] [Abstract][Full Text] [Related]
36. Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses.
Yoon JJ; Toots M; Lee S; Lee ME; Ludeke B; Luczo JM; Ganti K; Cox RM; Sticher ZM; Edpuganti V; Mitchell DG; Lockwood MA; Kolykhalov AA; Greninger AL; Moore ML; Painter GR; Lowen AC; Tompkins SM; Fearns R; Natchus MG; Plemper RK
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891600
[TBL] [Abstract][Full Text] [Related]
37. Oxymatrine Inhibits Influenza A Virus Replication and Inflammation via TLR4, p38 MAPK and NF-κB Pathways.
Dai JP; Wang QW; Su Y; Gu LM; Deng HX; Chen XX; Li WZ; Li KS
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29570670
[TBL] [Abstract][Full Text] [Related]
38. Identification of novel membrane-associated prostaglandin E synthase-1 (mPGES-1) inhibitors with anti-influenza activities in vitro.
Park JH; Park EB; Lee JY; Min JY
Biochem Biophys Res Commun; 2016 Jan; 469(4):848-55. PubMed ID: 26673392
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of respiratory syncytial virus replication by antisense oligodeoxyribonucleotides.
Jairath S; Vargas PB; Hamlin HA; Field AK; Kilkuskie RE
Antiviral Res; 1997 Feb; 33(3):201-13. PubMed ID: 9037376
[TBL] [Abstract][Full Text] [Related]
40. c-Jun N-terminal kinase activity is required for efficient respiratory syncytial virus production.
Caly L; Li HM; Bogoyevitch MA; Jans DA
Biochem Biophys Res Commun; 2017 Jan; 483(1):64-68. PubMed ID: 28062184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
